EP Global Communications, Inc. (EPGL: OTC Pink Current) | EP Global Communications, Inc. DTCC Chill Lift is Authorized


IRVINE, Calif., June 25, 2013 /PRNewswire/ — EP Global Communications, Inc. (the Company), (OTC-PINK: EPGL) is pleased to announce that DTCC counsel has confirmed their authorization for removal of the DTCC Chill on EPGL ticker.  The Company is also announcing that it will immediately move to file SEC forms for up-listing the Company to a higher stock exchange. “We have systematically been accomplishing our objectives, starting with the restructuring of the company, becoming OTC Current Information, launching our first medical device and now DTCC Chill lift.  We will now move forward with up-listing EPGL to higher stock exchanges,” said Michael Hayes, Company CEO.  “Our sole focus is to bring incredible Company value and returns to our shareholders and we wish to thank DTCC counsel for their hard work along with that of our own counsel to accomplish this major development,” Mr. Hayes added.

About EP Global Communications, Inc. / EPGL Medical

EP Global Communications, Inc. is a medical device manufacturer and marketing company with a world-class team of doctors and scientists on board.  The Company is currently marketing its first FDA cleared device with several additional “smart” medical devices under development.  The Company is the owner of the cutting edge technological platform for medical device development called “Topspin”.

Safe Harbor Statement

Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company’s statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company’s critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company’s control. The factors discussed herein and expressed from time to time in the Company’s filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

SOURCE EP Global Communications, Inc.

Leave a Reply